Point72 Asset Management’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-329,345
Closed -$6.44M 4045
2025
Q4
$6.44M Sell
329,345
-1,388,462
-81% -$26.3M 0.01% 1654
2025
Q3
$21.7M Buy
1,717,807
+1,594,523
+1,293% +$18.2M 0.05% 528
2025
Q2
$1.17M Sell
123,284
-1,405,250
-92% -$15.5M ﹤0.01% 1497
2025
Q1
$16M Buy
1,528,534
+603,853
+65% +$8.64M 0.04% 512
2024
Q4
$21.8M Buy
924,681
+822,201
+802% +$24.3M 0.06% 420
2024
Q3
$3.68M Sell
102,480
-255,038
-71% -$10.2M 0.01% 970
2024
Q2
$12.6M Sell
357,518
-328,916
-48% -$9.56M 0.04% 535
2024
Q1
$19.5M Buy
686,434
+297,234
+76% +$6.72M 0.06% 460
2023
Q4
$5.18M Sell
389,200
-186,600
-32% -$1.82M 0.02% 906
2023
Q3
$5.16M Buy
575,800
+147,271
+34% +$1.59M 0.02% 868
2023
Q2
$4.82M Sell
428,529
-492,606
-53% -$5.81M 0.02% 828
2023
Q1
$10.6M Sell
921,135
-466,533
-34% -$6.06M 0.04% 535
2022
Q4
$16.1M Sell
1,387,668
-109,963
-7% -$1.27M 0.06% 396
2022
Q3
$19M Buy
1,497,631
+131,231
+10% +$1.5M 0.08% 337
2022
Q2
$9.39M Sell
1,366,400
-521,500
-28% -$3.59M 0.04% 523
2022
Q1
$18.2M Buy
1,887,900
+633,100
+50% +$5.39M 0.08% 351
2021
Q4
$14.9M Buy
1,254,800
+427,800
+52% +$6.01M 0.07% 405
2021
Q3
$13.4M Buy
827,000
+146,100
+21% +$2.59M 0.06% 414
2021
Q2
$14.3M Buy
680,900
+327,785
+93% +$6.16M 0.07% 366
2021
Q1
$5.48M Buy
+353,115
New +$6.83M 0.03% 551
2020
Q4
Sell
-20,000
Closed -$404K 963
2020
Q3
$404K Buy
+20,000
New +$439K ﹤0.01% 833

Other funds holding DYN